Search Results - Thomas Silvers

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids by Beverly A. Teicher, Thomas S. Dexheimer, Li Chen, Thomas Silvers, Eric M. Jones, Nathan P. Coussens, J. Paul Eder, James H. Doroshow

    Published in Experimental and Molecular Pathology (2025-09-01)
    Get full text
    Article


  2. 2

    Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids by Nathan P. Coussens, Thomas S. Dexheimer, Thomas Silvers, Phillip R. Sanchez, Li Chen, Melinda G. Hollingshead, Naoko Takebe, James H. Doroshow, Beverly A. Teicher

    Published in SLAS Discovery (2025-06-01)
    Get full text
    Article


  3. 3

    Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids by Thomas S. Dexheimer, Zahra Davoudi, Nathan P. Coussens, Thomas Silvers, Joel Morris, Naoko Takebe, Rabih Said, Jeffrey A. Moscow, James H. Doroshow, Beverly A. Teicher

    Published in SLAS Discovery (2025-04-01)
    Get full text
    Article


  4. 4

    Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor by Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, Eric M. Jones, Li Chen, Jianwen Fang, Joel Morris, Jeffrey A. Moscow, James H. Doroshow, Beverly A. Teicher

    Published in SLAS Discovery (2024-10-01)
    Get full text
    Article


Search Tools: